Expect pharma growth to pick up in next quarter: Ajay Piramal

Piramal Group reported a good set of numbers for Q3, with topline and bottomline growth of more than 20 percent.

CNBC-TV18's Kevin Lee caught up with Ajay Piramal, Chairman of the company to discuss more on the Q3 performance and the outlook going ahead.

Piramal said that financial services business has grown by 68 percent and book stands at Rs 38,000 crore.

Talking about pharmaceutical business, he said he expects pharma growth to pick up in next quarter.